Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perspectives on the Home Monitoring of Macular Disease.
Miller JRC, Patel PJ, Hanumunthadu D. Miller JRC, et al. Among authors: hanumunthadu d. Ophthalmol Ther. 2023 Feb;12(1):1-6. doi: 10.1007/s40123-022-00632-6. Epub 2022 Dec 20. Ophthalmol Ther. 2023. PMID: 36538241 Free PMC article.
Characterising treatment outcomes of patients achieving quarterly aflibercept dosing for neovascular age-related macular degeneration: real-world clinical outcomes from a large tertiary care centre.
Fu DJ, Hanumunthadu D, Keenan TDL, Wagner S, Balsakas K, Keane PA, Patel PJ. Fu DJ, et al. Among authors: hanumunthadu d. Eye (Lond). 2023 Mar;37(4):779-784. doi: 10.1038/s41433-022-02220-1. Epub 2022 Sep 9. Eye (Lond). 2023. PMID: 36085360 Free PMC article.
Gender variation in central serous chorioretinopathy.
Hanumunthadu D, Van Dijk EHC, Gangakhedkar S, Goud A, Cheung CMG, Cherfan D, Sarvaiya C, Banker A, Meyerle C, Boon CJ, Singh R, Wu L, Chhablani J. Hanumunthadu D, et al. Eye (Lond). 2018 Nov;32(11):1703-1709. doi: 10.1038/s41433-018-0163-7. Epub 2018 Jul 9. Eye (Lond). 2018. PMID: 29988073 Free PMC article.
Systematic Review of Neovascular Age-Related Macular Degeneration Disease Activity Criteria Use to Shorten, Maintain or Extend Treatment Intervals with Anti-VEGF in Clinical Trials: Implications for Clinical Practice.
Patel PJ, Villavicencio P, Hanumunthadu D. Patel PJ, et al. Among authors: hanumunthadu d. Ophthalmol Ther. 2023 Oct;12(5):2323-2346. doi: 10.1007/s40123-023-00768-z. Epub 2023 Jul 21. Ophthalmol Ther. 2023. PMID: 37477856 Free PMC article. Review.
Variations in Treatment Delivery for Patients with Neovascular AMD in the UK: Results from an Ophthalmology Trainee Clinical Research Network Study.
Hanumunthadu D, Nowak VA, Hassan F, Hossain I, Patel DS, Hamidovic L, Abdulhussein D, Hausien I, Papamichael E, Arunakirinathan M, Quijano C, George S, Patel PJ; Ophthalmology Trainee Clinical Trial Network. Hanumunthadu D, et al. Ophthalmol Ther. 2017 Dec;6(2):295-300. doi: 10.1007/s40123-017-0104-8. Epub 2017 Aug 28. Ophthalmol Ther. 2017. PMID: 28849579 Free PMC article.
21 results